GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (FRA:CRO) » Definitions » Total Stockholders Equity

hVIVO (FRA:CRO) Total Stockholders Equity : €45.46 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is hVIVO Total Stockholders Equity?

hVIVO's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €45.46 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. hVIVO's Book Value per Share for the quarter that ended in Jun. 2024 was €0.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. hVIVO's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.34.


hVIVO Total Stockholders Equity Historical Data

The historical data trend for hVIVO's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Total Stockholders Equity Chart

hVIVO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.36 24.64 24.34 23.25 39.84

hVIVO Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.24 23.25 25.23 39.84 45.46

hVIVO  (FRA:CRO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

hVIVO's Book Value per Share for the quarter that ended in Jun. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

hVIVO's Debt-to-Equity for the quarter that ended in Jun. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


hVIVO Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of hVIVO's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


hVIVO Business Description

Industry
Traded in Other Exchanges
Address
42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

No Headlines